Krystal Biotech, Inc. - Common Stock - fluxo de caixa (NASDAQ:KRYS) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Fluxo de caixa operacional -26.08 M-47.94 M-100.57 M-88.8 M123.42 M200.87 M 250.28 M Fluxo de caixa de investimento -11.18 M-226.77 M-114.08 M82.64 M-163.44 M-58.42 M -67.23 M Fluxo de caixa de financiamento 118.02 M347.69 M35.35 M202.75 M27.01 M8.71 M 10.71 M Fluxo de caixa livre -26.08 M-47.94 M-100.57 M-88.8 M123.42 M188.91 M 237.38 M

Notícias

Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock

Krystal Biotech, Inc. (KRYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Ação da Krystal Biotech atinge máxima histórica de US$ 315,68

This Profitable Biotech Stealthily Climbs Into A Buy Zone

Krystal Biotech: Vyjuvek Is Not The Primary Asset (NASDAQ:KRYS)

Rocket Lab Soars 34%, Leads 10 Hot Prospects To IBD Best Stock Screens

Krystal Biotech, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KRYS) 2026-05-06

Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results - Krystal Biotech (NASDAQ:KRYS

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

BofA reduz preço-alvo da Krystal Biotech devido a mudança no mix de receita

Krystal Biotech supera expectativas de lucros no 1º tri de 2026

Krystal Biotech, Inc. (KRYS) Tops Q1 Earnings and Revenue Estimates